Insider · CIK 0001042047
OYLER JOHN
Reports to the SEC for 2 companies · BASEL
Transactions
50
Companies
2
Filings
1
CIK
0001042047
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-08-12 | ONCBeOne Medicines Ltd.S Sale | −$702K |
| 2026-08-12 | ONCBeOne Medicines Ltd.S Sale | −$896K |
| 2026-08-12 | ONCBeOne Medicines Ltd.S Sale | −$5.51M |
| 2026-08-12 | ONCBeOne Medicines Ltd.S Sale | −$7.49M |
| 2026-08-12 | ONCBeOne Medicines Ltd.S Sale | −$5.06M |
| 2026-08-11 | ONCBeOne Medicines Ltd.S Sale | −$4.92M |
| 2026-08-11 | ONCBeOne Medicines Ltd.S Sale | −$2.91M |
| 2026-08-11 | ONCBeOne Medicines Ltd.S Sale | −$5.27M |
| 2026-08-11 | ONCBeOne Medicines Ltd.S Sale | −$4.19M |
| 2026-08-11 | ONCBeOne Medicines Ltd.S Sale | −$4.87M |
| 2026-08-11 | ONCBeOne Medicines Ltd.S Sale | −$1.9M |
| 2026-08-11 | ONCBeOne Medicines Ltd.S Sale | −$1.16M |
| 2026-08-11 | ONCBeOne Medicines Ltd.S Sale | −$440K |
| 2026-08-11 | ONCBeOne Medicines Ltd.S Sale | −$1,468 |
| 2026-08-10 | ONCBeOne Medicines Ltd.S Sale | −$23.5K |
| 2026-08-10 | ONCBeOne Medicines Ltd.S Sale | −$990K |
| 2026-08-10 | ONCBeOne Medicines Ltd.S Sale | −$1.3M |
| 2026-08-10 | ONCBeOne Medicines Ltd.S Sale | −$2.38M |
| 2026-08-10 | ONCBeOne Medicines Ltd.S Sale | −$1.24M |
| 2026-08-10 | ONCBeOne Medicines Ltd.S Sale | −$4.43M |
| 2026-08-10 | ONCBeOne Medicines Ltd.S Sale | −$5.68M |
| 2026-08-10 | ONCBeOne Medicines Ltd.S Sale | −$16.2M |
| 2026-08-10 | ONCBeOne Medicines Ltd.S Sale | −$7.64M |
| 2026-08-10 | ONCBeOne Medicines Ltd.S Sale | −$1.33M |
| 2026-07-21 | ONCBeOne Medicines Ltd.S Sale | −$4.86M |
| 2026-07-21 | ONCBeOne Medicines Ltd.S Sale | −$6.35M |
| 2026-07-21 | ONCBeOne Medicines Ltd.S Sale | −$2.5M |
| 2026-07-21 | ONCBeOne Medicines Ltd.S Sale | −$5.05M |
| 2026-07-21 | ONCBeOne Medicines Ltd.S Sale | −$749K |
| 2026-07-20 | ONCBeOne Medicines Ltd.S Sale | −$1.6M |
| 2026-07-20 | ONCBeOne Medicines Ltd.S Sale | −$1.95M |
| 2026-07-20 | ONCBeOne Medicines Ltd.S Sale | −$906K |
| 2026-07-20 | ONCBeOne Medicines Ltd.M Exercise/Conversion | +$4.08M |
| 2026-07-20 | ONCBeOne Medicines Ltd.S Sale | −$4.84M |
| 2026-07-20 | ONCBeOne Medicines Ltd.S Sale | −$4.48M |
| 2026-07-20 | ONCBeOne Medicines Ltd.S Sale | −$581K |
| 2026-07-20 | ONCBeOne Medicines Ltd.S Sale | −$477K |
| 2026-07-20 | ONCBeOne Medicines Ltd.S Sale | −$165K |
| 2026-07-20 | ONCBeOne Medicines Ltd.S Sale | −$89.1K |
| 2026-07-20 | ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion | — |
| 2026-07-17 | ONCBeOne Medicines Ltd.M Exercise/Conversion | +$7.75M |
| 2026-07-17 | ONCBeOne Medicines Ltd.S Sale | −$439K |
| 2026-07-17 | ONCBeOne Medicines Ltd.S Sale | −$183K |
| 2026-07-17 | ONCBeOne Medicines Ltd.S Sale | −$210K |
| 2026-07-17 | ONCBeOne Medicines Ltd.S Sale | −$1.5M |
| 2026-07-17 | ONCBeOne Medicines Ltd.S Sale | −$1.73M |
| 2026-07-17 | ONCBeOne Medicines Ltd.S Sale | −$11.2M |
| 2026-07-17 | ONCBeOne Medicines Ltd.S Sale | −$4.67M |
| 2026-07-17 | ONCBeOne Medicines Ltd.S Sale | −$233K |
| 2026-07-17 | ONCBeOne Medicines Ltd.S Sale | −$16.1K |
Recent filings
- 4OYLER JOHN0001042047-26-000019SEC(opens sec.gov)
Companies
Address
C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR
BASEL, 4051